Kenneth H. Mayer, MD Prevention Science Core Director
Mailing Address:	The Miriam Hospital 164 Summit Avenue Providence, RI 02906
Telephone:	(401) 793-4710
Email:	Kenneth_Mayer@Brown.edu

Dr. Kenneth H. Mayer is a Professor of Medicine & Community Health at Brown University and Director of the Brown University AIDS Program. He is based in the Division of Infectious Diseases at The Miriam Hospital in Providence. He is also the Medical Research Director of the Fenway Community Health Center in Boston where he has conducted studies of the natural history and transmission of HIV since 1983. While doing his fellowship in Infectious Diseases at Harvard Medical School, Dr. Mayer was one of the first clinical researchers in Boston to see patients with AIDS and HIV infection. He also is an Adjunct Professor at the Harvard School of Public Health.

Dr. Mayer has been the Principal Investigator of an NIAID-supported study of the heterosexual transmission of HIV in Southeastern New England (starting in 1987) and was Co-Principal Investigator of the Centers for Disease Control-funded HIV Epidemiology Research Study (HERS) of the natural history of HIV in women, and the Principal Investigator of the New England Vaccine Preparedness Cohort Studies of the NIH national HIV vaccine field trial effort, known as HIVNET. He is now Principal Investigator of the NIH HIV Prevention Trials Network (HPTN) which focuses on microbicide studies in Rhode Island, as well as ART and prevention studies in Chennai. and co-Principal Investigator of the NIH HIV Vaccine Trials Network (HVTN).

Dr. Mayer has collaborated with basic virologists and immunologists to further characterize the genetics and immunopathology of HIV disease. He is on the National Board of Directors of the American Foundation for AIDS Research. He is an associate editor of the AIDS/Special Topics section of CLINICAL INFECTIOUS DISEASES, and on several editorial boards. He has published extensively on AIDS specifically on topics concerning the natural history, behavioral epidemiology, transmission variables, and public policy aspects of the epidemic.